155 related articles for article (PubMed ID: 4359117)
1. Type IV hyperlipoproteinaemia.
Kwiterovich PO; Margolis S
Clin Endocrinol Metab; 1973 Mar; 2(1):41-71. PubMed ID: 4359117
[No Abstract] [Full Text] [Related]
2. Type 3 hyperlipoproteinaemia.
Eisenberg S
Clin Endocrinol Metab; 1973 Mar; 2(1):111-25. PubMed ID: 4359114
[No Abstract] [Full Text] [Related]
3. Xanthomatosis and hyperlipoproteinemia; a review.
Polano MK
Dermatologica; 1974; 149(1):1-9. PubMed ID: 4372111
[No Abstract] [Full Text] [Related]
4. Type V hyperlipoproteinaemia.
Gotto AM
Clin Endocrinol Metab; 1973 Mar; 2(1):11-39. PubMed ID: 4359115
[No Abstract] [Full Text] [Related]
5. Type II hyperlipoproteinaemia.
Myant NB; Slack J
Clin Endocrinol Metab; 1973 Mar; 2(1):81-109. PubMed ID: 4361963
[No Abstract] [Full Text] [Related]
6. Lipoproteins and hyperlipoproteinaemia.
Rifkind BM
Clin Endocrinol Metab; 1973 Mar; 2(1):3-10. PubMed ID: 4359116
[No Abstract] [Full Text] [Related]
7. [Familial hyperlipoproteinemia type III].
Patsch JR; Patsch W; Sailer S; Braunsteiner H
Dtsch Med Wochenschr; 1976 Oct; 101(44):1612-9. PubMed ID: 185039
[No Abstract] [Full Text] [Related]
8. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
Gustafson A
Postgrad Med J; 1975; 51(8):suppl 66-71. PubMed ID: 215983
[No Abstract] [Full Text] [Related]
9. Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia.
Patsch JR; Yeshurun D; Jackson RL; Gotto AM
Am J Med; 1977 Dec; 63(6):1001-9. PubMed ID: 204188
[No Abstract] [Full Text] [Related]
10. Dietary and drug treatment of primary hyperlipoproteinemia.
Ann Intern Med; 1972 Aug; 77(2):267-94. PubMed ID: 4345081
[No Abstract] [Full Text] [Related]
11. A physician's guide to hyperlipidemia.
Fredrickson DS
Mod Concepts Cardiovasc Dis; 1972 Jul; 41(7):31-6. PubMed ID: 4343098
[No Abstract] [Full Text] [Related]
12. Altering lipid patterns in adult males.
Appelbaum JJ; Amundsen MA; Perkin DK
J Occup Med; 1974 Aug; 16(8):539-42. PubMed ID: 4367267
[No Abstract] [Full Text] [Related]
13. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].
Weisweiler P; Schwandt P
Klin Wochenschr; 1977 Aug; 55(16):791-4. PubMed ID: 198601
[TBL] [Abstract][Full Text] [Related]
14. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy.
Falko JM; Witztum JL; Schonfeld G; Weidman SW; Kolar JB
Am J Med; 1979 Feb; 66(2):303-10. PubMed ID: 218451
[No Abstract] [Full Text] [Related]
15. Bile acid metabolism in hyperlipoproteinaemia.
Hellström K; Einarsson K
Clin Gastroenterol; 1977 Jan; 6(1):103-28. PubMed ID: 196796
[No Abstract] [Full Text] [Related]
16. Treatment of hyperlipidemia.
Levy RI; Morganroth J; Rifkind BM
N Engl J Med; 1974 Jun; 290(23):1295-301. PubMed ID: 4363888
[No Abstract] [Full Text] [Related]
17. Management of hyperlipidemias.
Murphy BF
JAMA; 1974 Dec 23-30; 230(12):1683-91. PubMed ID: 4373590
[No Abstract] [Full Text] [Related]
18. The hyperlipidemias and coronary artery disease.
Stone NJ; Levy RI
Dis Mon; 1972 Aug; ():1-35. PubMed ID: 4340135
[No Abstract] [Full Text] [Related]
19. Type I hyperlipoproteinaemia.
Brown WV; Greten H
Clin Endocrinol Metab; 1973 Mar; 2(1):73-80. PubMed ID: 4359118
[No Abstract] [Full Text] [Related]
20. A double-blind comparison of the hypolipidemic and hypouricemic action of halofenate and clofibrate in patients with hyperlipoproteinemia (types III, IV and V).
Neuman J; de Neuman MP; Talmasky S; Pesce R; Valero E; Martiarena JL
J Cardiovasc Surg (Torino); 1973; Spec No():532-7. PubMed ID: 4377715
[No Abstract] [Full Text] [Related]
[Next] [New Search]
